Ozempic (semaglutide) is a widely used prescription medication for type-2 diabetes and weight management. Recent scientific studies indicate that higher doses of Ozempic can lead to gallstones and gallbladder disease, often requiring surgical intervention for gallbladder removal. Research has also shown that Ozempic can cause gastroparesis, a a serious condition that causes food to move too slowly through the stomach to the small intestine.
Until recently, the warning label for Ozempic failed to inform patients and physicians about the risk of gallbladder-related issues or gastroparesis. Individuals who experienced gallbladder disease or gastroparesis after using Ozempic may have grounds for financial compensation through a product liability lawsuit. Lawsuits against the drug’s manufacturers emerged in 2023 and will soon be consolidated into an Ozempic class action lawsuit.
For those involved in an Ozempic-related gallbladder lawsuit, contact our attorneys today at 800-322-3010 or reach out online for a complimentary consultation.